No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

byKathleen Lau

August 27, 2021

in StudyGraphics

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

RelatedReports

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]

Pharma

Apixaban reduces bleeding risk versus rivaroxaban in acute venous thromboembolism

March 23, 2026

Variation noted across pre- and post-marketing studies for FDA approved devices

Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026

Pediatric palliative care outcome measures often miss quality of life

Pediatrics

Isotonic Fluids Reduce Hyponatremia in Hospitalized Children

February 4, 2026

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026

Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

VieScope as a comparable alternative to Macintosh and Glidescope laryngoscopy for securing difficult airways

Reduced gestational weight gain with lifestyle intervention

Health wearable devices effectively promote bodyweight in overweight/obese individuals

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Continuous electrocardiogram monitoring following discharge detects atrial fibrillation in postoperative cardiac patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports